The SARS-CoV-2 virus that causes COVID-19 continues to evolve, with a new variant becoming predominant in the United States. Data from the Centers for...
In the ongoing Omicron era, a new COVID-19 antibody could renew optimism for urgently required SARS-CoV-2 monoclonal therapies. Over the last three years, various...